Literature DB >> 5489700

The notochord as an abnormal organizer in production of congenital intestinal defect.

G B Elliott, S J Tredwell, K A Elliott.   

Abstract

Entities:  

Mesh:

Year:  1970        PMID: 5489700     DOI: 10.2214/ajr.110.3.628

Source DB:  PubMed          Journal:  Am J Roentgenol Radium Ther Nucl Med        ISSN: 0002-9580


× No keyword cloud information.
  8 in total

Review 1.  Animal models in pediatric surgery.

Authors:  A Mortell; S Montedonico; P Puri
Journal:  Pediatr Surg Int       Date:  2005-12-06       Impact factor: 1.827

2.  Adriamycin-Induced Models of VACTERL Association.

Authors:  D Mc Laughlin; P Hajduk; P Murphy; P Puri
Journal:  Mol Syndromol       Date:  2013-02

3.  Secondary teratogenic factors.

Authors:  L M Gonzalo-Sanz; J L Velayos
Journal:  Experientia       Date:  1974-07-15

Review 4.  Treatment landscape of triple-negative breast cancer - expanded options, evolving needs.

Authors:  Giampaolo Bianchini; Carmine De Angelis; Luca Licata; Luca Gianni
Journal:  Nat Rev Clin Oncol       Date:  2021-11-09       Impact factor: 66.675

5.  Abnormalities of the vertebral column and ribs associated with anorectal malformations.

Authors:  Bao Quan Qi; Spencer W Beasley; Dejan Arsic
Journal:  Pediatr Surg Int       Date:  2004-06-16       Impact factor: 1.827

6.  Pallister-Hall syndrome and McKusick-Kaufmann syndrome: one entity?

Authors:  K M Unsinn; N Neu; A Krejci; A Posch; G Menardi; I Gassner
Journal:  J Med Genet       Date:  1995-02       Impact factor: 6.318

7.  Notochord manipulation does not impact oesophageal and tracheal formation from isolated foregut in 3D explant culture.

Authors:  Danielle Mc Laughlin; Paula Murphy; Prem Puri
Journal:  Pediatr Surg Int       Date:  2015-11-07       Impact factor: 1.827

8.  Increased fibronectin expression in developing embryos is associated with abnormal notochord in the Adriamycin rat model.

Authors:  A Mortell; A M O'Donnell; S Giles; J Bannigan; P Puri
Journal:  Pediatr Surg Int       Date:  2004-02-18       Impact factor: 1.827

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.